1. Shanley, Mayra, Daher, May, Dou, Jinzhuang, Chen, Ken, Rezvani, Katayoun. . Interleukin-21 engineering enhances NK cell activity against glioblastoma via CEBPD. In Cancer cell, 42, 1450-1466.e11. doi:10.1016/j.ccell.2024.07.007. https://pubmed.ncbi.nlm.nih.gov/39137729/
2. Moseti, Dorothy, Regassa, Alemu, Kim, Woo-Kyun. 2016. Molecular Regulation of Adipogenesis and Potential Anti-Adipogenic Bioactive Molecules. In International journal of molecular sciences, 17, . doi:10.3390/ijms17010124. https://pubmed.ncbi.nlm.nih.gov/26797605/
3. Huang, A-Mei, Rudelius, Martina, Sharan, Shikha, Christenson, Lane K, Sterneck, Esta. 2007. The Cebpd (C/EBPdelta) gene is induced by luteinizing hormones in ovarian theca and interstitial cells but is not essential for mouse ovary function. In PloS one, 2, e1334. doi:. https://pubmed.ncbi.nlm.nih.gov/18092000/
4. Pan, Yen-Chun, Li, Chien-Feng, Ko, Chiung-Yuan, Sterneck, Esta, Wang, Ju-Ming. 2010. CEBPD reverses RB/E2F1-mediated gene repression and participates in HMDB-induced apoptosis of cancer cells. In Clinical cancer research : an official journal of the American Association for Cancer Research, 16, 5770-80. doi:10.1158/1078-0432.CCR-10-1025. https://pubmed.ncbi.nlm.nih.gov/20971808/
5. Wang, Tzu-Yun, Weng, Eddie Feng-Ju, Hsu, Yun-Chen, Hong, Jau-Shyong, Wang, Shao-Ming. 2024. Inhibition of MMP8 effectively alleviates manic-like behavior and reduces neuroinflammation by modulating astrocytic CEBPD. In Journal of neuroinflammation, 21, 61. doi:10.1186/s12974-024-03054-2. https://pubmed.ncbi.nlm.nih.gov/38419037/
6. Sun, Ying, Jia, Li, Williams, Michael T, Witte, David P, Grabowski, Gregory A. 2008. Temporal gene expression profiling reveals CEBPD as a candidate regulator of brain disease in prosaposin deficient mice. In BMC neuroscience, 9, 76. doi:10.1186/1471-2202-9-76. https://pubmed.ncbi.nlm.nih.gov/18673548/